Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders (MTT-ASD)
Sponsor: Arizona State University
A PHASE2 clinical study on Autism Spectrum Disorder and Gastrointestinal Disorder, this trial is ongoing. The trial is conducted by Arizona State University and has accumulated 11 data snapshots since 2018. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
11 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting PHASE2
Status: Unknown → Active Not Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Unknown PHASE2
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 6 earlier versions
-
Jan 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arizona State University
For direct contact, visit the study record on ClinicalTrials.gov .